NASDAQ : EUCR

Eucrates Biomedical Acquisition Corp. — SEC Filings

$10.04 USD

$0 (0.0%)

Volume
12.7K
Average Volume
1.66K
Market Capitalization
$42.23M
P/E Ratio
5.40
Dividend Yield
0.00%
Price Target
Year High
$10.25
Year Low
$9.87
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.03
EUCR SEC Filings
Company Symbol Filed Form Type View
EUCR 2023-05-08 06:03:47 15-12G
EUCR 2023-04-26 16:52:14 25-NSE
EUCR 2023-04-13 16:50:03 10-K
EUCR 2023-04-11 17:00:33 8-K
EUCR 2023-04-03 16:15:52 8-K
EUCR 2023-03-29 16:40:30 NT 10-K
EUCR 2023-02-16 16:13:24 8-K
EUCR 2023-02-10 09:43:19 SC 13G/A